NEW YORK, Jan. 30, 2025 /PRNewswire/ — ProofPilot, the leading Clinical Experience Platform (CXP) that enhances engagement for sponsors, sites, and patients, today announced its participation at the 16th Annual SCOPE Summit for Clinical Ops Executives. With a dynamic presence planned, ProofPilot will highlight its revolutionary recruitment and study engagement capabilities.
SCOPE 2025 Highlights
About Pharma Feud
In this match, two pharma teams will compete to quickly guess the most popular answers to site responses about patient recruitment engagement, efficiency, and strategy. The event will feature insights from six esteemed Sponsors in the pharma industry.
“At ProofPilot, we understand how complex dynamics impact the overall success of trial recruitment,” Chris Venezia, Chief Executive Officer of ProofPilot, said. “Pharma Feud will reveal some little-known truths determining the success of patient recruitment strategies, and how our solution is built to improve this for patients, sites, and sponsors.”
About ProofPilot
ProofPilot is a comprehensive Clinical Experience Platform (CXP) that redefines the design, management, and execution of clinical trials through digital innovation. With over 10 years of experience, ProofPilot’s CoPilot platform supports a wide range of research, making clinical trials more efficient and patient-friendly. Learn more at https://www.proofpilot.com.
Stay informed about ProofPilot news at https://www.linkedin.com/company/proofpilot
Media Contact: Hope McCain, hope.mccain@proofpilot.com
SOURCE ProofPilot
Company to also highlight advancements in denials and underpayments management and speak to the measurable…
Next generation analyzer helps hospitals protect revenue before it's lost by delivering timely end-to-end visibility…
Data presented simultaneously at the American Diabetes Association’s® 85th Scientific Sessions, showed mean weight reduction…
Dr. Anosh Ahmed repurposes West Side warehouse into blockchain innovation center, targeting 250+ jobs and…
Dr. Anosh Ahmed converts vacant West Side warehouse into blockchain innovation hub, creating 250+ jobs…
Treatment with apelin receptor agonist enhanced glycemic control and demonstrated cardioprotective effects, with additive benefits…
![](data:image/svg+xml;charset=utf-8,<svg height="32px" width="32px" xmlns="http://www.w3.org/2000/svg" version="1.1"/>)
![](data:image/svg+xml;charset=utf-8,<svg height="12px" width="12px" xmlns="http://www.w3.org/2000/svg" version="1.1"/>)
![](data:image/svg+xml;charset=utf-8,<svg height="400px" width="1000px" xmlns="http://www.w3.org/2000/svg" version="1.1"/>)
